Clinical trials technology provider VirTrial has formed an alliance to enable virtual clinical trials at Pratia clinical research centres in Europe.

All Pratia sites have undergone VirTrial’s Virtual Trial Capable training, becoming the first Virtual Trial Capable site network in Europe.

The training programme comprises four modules that must be completed by clinical research professionals for competency in general telemedicine etiquette and guidelines, and use of the VirTrial platform.

VirTrial added that participants who complete the training will be prepared to perform hybrid decentralised clinical trials (DCT).

Pratia managing director Małgorzata Gerjatowicz-Osmańska said: “Embracing telehealth technologies that enable a larger patient population to participate supports our goal and we’re proud to be the first network in Europe to offer this benefit to sponsors.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Our network is expanding across Europe and we plan to maintain our 100% Virtual Trial Capable status with VirTrial to best serve our patients and pharma sponsors.”

VirTrial offers a telehealth platform, which provides a virtual care management (VCM) programme combining video, text, and email to allow organisations to create patient-centric trials via the replacement of certain study visits with virtual visits.

The VCM programme can be used to review and assess patient compliance and is ideal for Phase III/Phase IV trials where compliance can be evaluated from any location.

VirTrial business development vice-president Amanda Rangel said: “The innovative VirTrial telehealth platform was developed by clinical research professionals and we are committed to continued collaboration with sites and supporting site sustainability in the new era of hybrid decentralised trials.”

VirTrial recently received a hybrid decentralised clinical trial (DCT) with Hope Biosciences. The trial protocol includes remote visits through VirTrial’s telehealth platform.